ABSTRACT
Although the clinical need for bioengineered blood vessels is growing, options for vascular conduits are currently limited. The aim of this study is to develop a novel scaffold fabrication method for use as a small‐diameter vascular graft and to evaluate its biocompatibility, cell attachment, and mechanical properties. This scaffold consists of a tubular polycaprolactone parallel nanofiber section (a seamless tube of fibers aligned along the long axis) reinforced with 4‐axis 3D printed spiral polycaprolactone. The final structure was coated with collagen and cultured with various cells. High‐resolution field emission‐scanning electron microscopy images confirm the successful fabrication of seamless parallel fibrous tubes (as small as 300 µm) and fusion of the fibers to the spiral reinforcement. Biocompatibility assays on the scaffold indicate no cell toxicity, and the parallel fibers successfully oriented the cells cultured inside the tube, thereby mimicking their natural orientation in vascular tissue. The spiral reinforcement was successfully attached to the inner tube, which significantly improved the tube's mechanical strength compared to the non‐reinforced groups. These results suggest that this new fabrication method of polycaprolactone/collagen parallel tubular nanofibers reinforced by using 4‐axis 3D printing techniques could play a promising role in future bioengineered vascular tissues or other tubular tissues.
Keywords: 3D printing, conduit, electrospinning, tow‐pole electrospinning, tubular scaffold, vascular tissue engineering
We introduce a new fabrication method that overcomes the current limitation of tubular gap electrospinning. We successfully fabricated a seamless hollow tube with fibers aligned along the longitudinal axis in diameters as small as 300 µm, and then reinforced it using 4‐axis 3D printing. This tube can be used in various tissues, such as small‐diameter vascular grafts.

1. Introduction
Cardiovascular diseases have now surpassed cancer as the leading cause of mortality globally [1]. The need for small‐diameter vascular grafts (SDVGs) has increased substantially due to the rising prevalence of cardiovascular diseases, including peripheral arterial occlusive disease and coronary artery disease. These conditions often require surgical procedures to replace small arteries (inner diameter ≤ 6 mm), thus highlighting the importance of effective vascular graft options. Autologous procedures using blood vessels, such as the radial artery, internal mammary artery, and great saphenous vein, are considered the gold standard for SDVGs due to their high patency and low risk of immune rejection [2]. However, many patients lack suitable veins for harvesting, thereby reducing treatment options, and the increased risk of infection associated with secondary trauma following these procedures has further limited their application [3]. These shortcomings highlight the need for alternative approaches, such as tissue engineering technology, to fabricate SDVGs that meet patient‐specific needs [4]. Tissue engineering methods for constructing SDVGs can be classified into decellularization‐based processing [5, 6, 7], cell‐sheet engineering [8, 9], molding techniques [10, 11, 12, 13], and scaffold‐based processing [14, 15, 16].
1.1. Tubular Tissues
These share common structural traits despite their different roles; each is typically organized in lamellar layers encircling an internal space known as the lumen to facilitate the transport and storage of specific substances. The lumen is lined with an epithelial layer (the endothelium in blood vessels) that acts as a barrier separating the lumen's contents from the surrounding tissues and organs, thereby enabling selective transport and permeability. The epithelial layer rests on an extracellular matrix (ECM) that provides structural support [17]. The ECM layer generally consists of cells embedded in connective tissue and includes various proteins, such as collagen and elastin. Additional tissue layers can be present depending on the tissue's function. For example, blood vessels have a smooth muscle layer that facilitates vasodilation and vasoconstriction, which is crucial for maintaining blood circulation and blood pressure [18].
1.2. Polycaprolactone (PCL)
This polymer is a suitable candidate for tissue engineering due to its safety and biocompatibility [19]. PCL has been increasingly utilized in the development of SDVGs, primarily due to its favorable mechanical properties and biodegradability that make it particularly suitable for cardiovascular applications. The effectiveness of PCL‐based vascular grafts has been widely reported [20, 21, 22, 23], thus indicating their potential to address common limitations associated with synthetic alternatives that often fail at diameters less than 6 mm, along with poor long‐term patency and insufficient biocompatibility. However, the poor hydrophilicity and cytocompatibility of PCL make it unfavorable for creating cell‐friendly scaffolds, which makes the surface modification of PCL fibers without altering their bulk properties essential [24].
1.3. Collagen
This is widely recognized as a crucial component of the ECM, which plays a vital role in various tissues and organs. Specifically, collagens comprise up to 40% of the total protein in the vessel wall [25, 26]. Also, collagen coating has been used previously to improve the PCL surface hydrophilicity [24, 27].
1.4. Electrospinning
Biobased chemical nanofibers have paralleled the development of nanotechnology and nanoscience in three directions (size, order, structures/devices). But the nano and micro fabrication of functional materials encounters unavoidable challenges, like great difficulty in industrialization and high product cost. Electrospinning and electrospun nanofibers have the potential to solve these issues [28]. Development of Electrospinning has continued to multiple specialized multi‐fluid techniques (core–sheath, side‐by‐side, tri‐layer, and combos) that enable precise spatial arrangement of composition at the nanoscale for developing novel functional materials. Together, these capabilities create rich process–structure–performance relationships by selecting electrospinning modality, materials, and process parameters [29, 30, 31]. Electrospinning is also moving forward in two other directions, namely the large‐scale production of potential commercial products and the combination with other advances and traditional techniques to create new nanodevices [32, 33]. Our work lies at the intersection of “order and medicated nanodevices.”
1.5. Previous Electrospinning Techniques and Their Limitations
First described by Li et al. in 2003 [34], gap electrospinning uses fiber collection across two parallel electrodes to achieve a high degree of fiber alignment (Figure S1A) [35]. Fiber alignment is driven by electrostatic forces that guide the polymer jet during fiber deposition onto the collector [36]. In its most basic form, electrospun fibers are collected between two parallel electrodes (either charged or grounded) separated by a void or a substrate that acts as an insulator [37]. Compared with a plate collector that has no preferential electric field line direction, parallel electrodes induce an alteration to the electric field, whereby the field lines point toward the electrodes [38, 39]. This electric field alteration causes fibers to span the electrodes perpendicular to the electrode edge, resulting in a high degree of fiber alignment [40]. Although gap electrospinning permits the fabrication of highly aligned meshes and unique microarchitectural modulations, controlling the size and thickness of the mesh is limited. Researchers have noted that residual charge can build up with an increase in the thickness of the mesh. Over time, the increase in residual charge results in repulsion and a loss of fiber alignment as the mesh becomes thicker, resulting in the deposition of fibers in an increasingly random orientation [40].
Jha et al. [41] produced a 3D cylindrical scaffold with longitudinally aligned fibers by utilizing a two‐pole setup (Figure S1B). Although this method can produce a conduit for direct axon growth during nerve regeneration by bridging the gap between severed nerves due to trauma, which makes end‐to‐end anastomosis unfavorable, the minimum size of the conduit was 19 mm. Although two‐pole electrospinning (TPE) has also been used to fabricate tubular conduits [42], this concept has limited applicability due to the following flaws. First, the minimum size that can be fabricated is limited to approximately 3 mm (as observed in the present study). For sizes smaller than this, the inner lumen becomes filled with fibers, so the conduit can no longer function as a tube. Second, it cannot sustain its tubular shape after detachment from the electrospinning machine and collapses on itself. Third, for applications like blood vessels, only a few layers of fibers are needed for the conduit (for transferring gases and nutrition), which is impossible to construct via TPE due to the fragile nature of the resulting nanostructures. Moreover, adding more layers to the scaffold's fibers makes their alignment more random than parallel, which eventually negates the main advantage of the tube [43].
1.6. 3D Printing
The advent of 3D printing technology has significantly transformed the landscape of tissue engineering by enabling the fabrication of complex structures [44]. One major shortcoming of 3D printing is its low resolution, which prevents it from replicating the fine microarchitectural details inherent to native tissues. Conventional 3D printing fabrication techniques can achieve resolutions ranging from 100 to 200 µm [45], which is too large to replicate the ECM.
1.7. Aim of This Study
This study aims to develop a novel technique to fabricate parallel nanofibrous tubes as a seamless, integral vascular scaffold structure. Unlike conventional tubes formed by rolling a flat sheet, we developed a novel technique to fabricate parallel nanofibrous tubes as a seamless integral structure. This is the first successful fabrication of seamless parallel fibrous tubes with diameters of 1.75 mm and as small as 300 µm. This was achieved by leveraging the strengths of both electrospinning and 3D printing techniques, thereby overcoming the limitations of TPE's low mechanical strength and 3D printing's low manufacturing precision. This structure was then used as a vascular scaffold upon which human umbilical vein endothelial cells (HUVECs; PCS‐100‐013, ATCC, USA) and smooth muscle cells (SMCs, PCS‐100‐021, ATCC, USA) were co‐cultured. Cell viability studies show that the vascular structure was non‐toxic, and the parallel fibers could successfully orient the cells to mimic their natural orientation in the vascular system. Adding the 3D printed reinforcement successfully increased the mechanical strength of the tubes while keeping their inner fibrous structure intact. Cellular immunohistochemistry staining and imaging confirmed the successful seeding of the SMCs and HUVECs on the PCL scaffold, which was improved by coating it first with collagen.
2. Materials and Methods
2.1. Scaffold
The scaffold consists of two different parts, the electrospinning part and the 3D printed part (Figure S2). The inner side of the tube consists of parallel fibers created through electrospinning, and the outer part (made through 4‐axis 3D printing) provides a spiral support structure for the inner fragile fibers.
2.1.1. The Inner Part
First, PCL (average M n = 80,000; Sigma, USA) was dissolved in dichloromethane (Daejung, Busan, South Korea) and dimethylformamide (Daejung, Busan, South Korea) (80:20). The solution was then shaken at room temperature to promote homogeneity. Subsequently, the solution was allowed to rest for 10 min to dissipate any bubbles. Next, the solution was extruded using a 23G syringe on a custom‐made collector under 20 kV at a flow rate of 2 mL h−1 [27]. The collector comprises polyvinyl alcohol (PVA) as a sacrificial material (Sindoh, South Korea) coated with gold using an MCM‐100 ion sputter coater (SEC, South Korea) set at a discharge current of 13 mA under vacuum for 5 min. The center of the sacrificial material was covered with Scotch tape to prevent gold coating, and then the two ends of the PVA filament were coated with a nano‐layer of gold.
2.1.2. The Outer Part
The outer reinforcement was fabricated using a 4‐axis 3D printing system consisting of a Rokit Invivo 3D printer (Rokit Healthcare, South Korea) and a custom‐made rotary receiver. To ensure complete melting of the PCL, it was preheated from 90 to 150°C for 30 min in the extruder. Subsequently, the melted PCL was extruded into filaments at 90, 130, and 150°C with 600 kPa air pressure using nozzles with diameters of 0.3, 0.6, and 1 mm, respectively (equivalent to groups 0.3, 0.6, and 1). A non‐reinforced tube serves as the control group. The extrusion nozzle moved along the central shaft of the receiver at various speeds. The cylindrical receiver 1.75 mm in diameter, was rotated constantly at 60 RPM. More details of the 3D printing parameters are provided in Table S1, while Figure S3 shows a schematic of the 4‐Axis 3D printer.
2.2. Fiber Orientation and Diameter Analysis
Since PCL is a poor electrically conductive material [46], three 1 × 1 cm sections were cut from the flat scaffold and coated with gold, which is an excellent electron emitter used for FE‐SEM imaging [47]. Three representative FE‐SEM images of each sample were obtained, and the diameter and orientation of 175 distinct fibers were measured using ImageJ (NIH, USA). The images taken at 1,000X magnification were used to measure the fiber diameter. The angle of each fiber relative to the x‐axis was taken as the fiber orientation. Graphs of fiber diameter distribution and fiber orientations were obtained using Origin software (version 2019b).
2.3. Collagen Coating
Collagen was immobilized on the PCL fibers via aminolysis to enhance the cytocompatibility of the latter by mimicking the natural chemistry of vessel tissues. The fabricated scaffolds were washed by immersion in a 50% v/v ethanol solution for 3 h, followed by rinsing with deionized (DI) water to eliminate oily contaminants. They were then immersed in a 10% w/v hexandiamine/2‐propanol solution at 37°C for 24 h, followed by rinsing with DI water for another 24 h. Subsequently, the scaffolds were soaked in a 1% w/v glutaraldehyde solution for 3 h at 25°C, washed three times with DI water, and then immersed in DI water for 24 h to remove unreacted glutaraldehyde molecules. Finally, the amine‐functionalized nanofiber mats were immersed in a solution of type I collagen (3 mg/mL; PC‐001‐1 g, Dalim Tissen, Porkskin, South Korea) at pH 3.4, followed by incubation at 4°C for 24 h. Finally, the collagen‐coated scaffolds were rinsed with DI water and dried at room temperature [24].
2.4. Sirius Red Staining
This was conducted to confirm the success of the collagen coating of the scaffolds. Sirius red stains collagen with an orange‐to‐red color due to the reaction between sirius red's sulphonic acid groups and the basic groups in the collagen molecule [48]. To this end, picrosirius red solution and acidic water were used to stain the collagen coating on the scaffold. The fabricated scaffold was first soaked in the picrosirius red solution for 1 h to reach equilibrium during staining, after which it was rinsed twice with acidic water solution made by mixing 0.5% acetic acid with DI water [49]. For comparison, both uncoated and collagen‐coated samples were examined using polarized light microscopy.
2.5. High‐Performance X‐Ray Photoelectron Spectroscopy (XPS)
High‐performance XPS (K‐Alpha+, Thermo Fisher, USA) was used to verify the successful surface‐modification process. A standard N1s survey scan was conducted to examine the functional groups in uncoated (PCL), hexanediamide‐treated (PCL‐Hexan), and collagen‐coated PCL fibers (PCL‐Col) [24].
2.6. Water Contact Angle Measurements
Water contact angle measurements to ascertain the wettability of the scaffold's surface were taken using a goniometer (SEO Phoenix 300, Korea): the lower the contact angle, the more hydrophilic the surface. Better hydrophilicity may improve mammalian cell attachment to the scaffold. After placing the scaffold on a glass slide, a 10 µL droplet of DI water was placed thereon, and the water contact angle was measured after 15 s at room temperature and 50% relative humidity [50].
2.7. Mechanical Strength Testing
2.7.1. Circumferential Tensile Strength and Burst Pressure
Circumferential tensile strength testing was carried out on a tubular scaffold (10 mm in length) in a tensile tester at a rate of 0.6 mm/min. Circumferential tensile strength (CTS) is defined as the maximum stress reached before the sample fractures [51]. The burst pressure of the tubular scaffold has been estimated from the CTS value using an adaptation of Laplace's law for intraluminal pressure [52, 53].
where T is the thickness of the tubular scaffold, and R is the intraluminal radius of the tubular scaffold at atmospheric pressure.
2.7.2. Suture‐Retention Strength
To maintain the tubular shape of the tubular scaffold (10 mm in length), one end was secured in polydimethylsiloxane (PDMS; Dow Corning, Midland, United States) and then mounted on the uniaxial test machine's clamp. Meanwhile, the other end was connected to another clamp via suturing (5‐0 Prolene; Ethicon, New Jersey, United States) 2 mm from the edge of the specimen. The distance between the clamps was 1.5 cm. Testing was carried out at a crosshead speed of 8 mm/min until the membrane fractured [51].
2.7.3. Longitudinal Tensile Strength
To maintain the tubular shape, a piece of stainless steel matching the inner size of the tube was glued to the end of the scaffold, and the steel part was mounted to the tensile machine clamps. Longitudinal tensile testing was then performed at a crosshead speed of 5 mm/min [54]. The longitudinal tensile strength is defined as the maximum stress applied during the tensile test before fracturing occurs.
2.8. Cell Viability and Proliferation
HUVECs were used to evaluate cell viability and proliferation on the scaffold. To this end, cells were seeded at 5 × 103 cells per well on the scaffold in 24‐well plates and cultured for 1, 3, and 7 days in Vascular Cell Basal Medium (PCS‐100‐030; ATCC, Manassas, United States) supplemented with Endothelial Cell Growth Kit‐BBE (PCS‐100‐040; ATCC, Manassas, United States) and 1% antibiotic–antimycotic (100×) (Gibco, Waltham, United States). Every 2–3 days, the culture medium was replaced with fresh medium. Standard 24‐well plates (SPL, Pocheon, South Korea) were used for the positive control group, and ultralow attachment plates (SPL, Pocheon, South Korea) were used for the test groups. Cell proliferation and viability were measured using the WST assay, in which a water‐soluble tetrazolium salt (WST‐1; EZ‐CYTOX, Dogen Bio Co, Seoul, South Korea) solution was added to each well to create a 10% solution, followed by incubation for 1 h. Next, the samples were gently shaken for 1 min. The optical density of the extracted solution was analyzed using a microplate reader (Synergy H1 Hybrid Multi‐Mode Reader, BioTek, Winooski, United States) at an absorbance wavelength of 450 nm (n = 6) [55, 56].
2.9. Live and Dead Assay
After culturing HUVECs on the flat scaffold for 7 days in the same culture media conditions as the cell viability testing, the scaffold was placed on a cover glass in a custom‐made chamber. Meanwhile, stock dye solutions were warmed to room temperature and vortexed to ensure they were well mixed, and a staining solution comprising 2 µM calcein AM and 4 µM EthD‐III was prepared by adding 5 µL of 4 mm calcein AM and 20 µL of 2 mm EthD‐III to 10 mL of 1X phosphate‐buffered saline (PBS; Gibco, Waltham, United States) and vortexing to ensure thorough mixing. Subsequently, cells were washed twice with PBS to eliminate serum esterase activity, and then a sufficient volume of the staining solution was added to cover the scaffold, followed by incubation for 30 min at room temperature. Labeled cells were imaged via confocal microscopy using an FITC filter set for calcein and a Texas red filter set for EthD‐III [57].
2.10. Cell Attachment and Orientation Analysis
HUVEC cells were seeded at 5 × 104 cells per well on a flat collagen‐coated scaffold in a 24‐well plate (Corning, New York, United States) and cultured for 7 days in Vascular Cell Basal Medium (PCS‐100‐030; ATCC, Manassas, United States) supplemented with Endothelial Cell Growth Kit‐BBE (PCS‐100‐040; ATCC, Manassas, United States) and 1% antibiotic–antimycotic (100×) (Gibco, Waltham, United States). Afterward, cells were fixed with 2.5% glutaraldehyde for 2 h at room temperature, then washed twice with PBS. The cells were used as‐prepared for FE‐SEM or stained with crystal violet and imaged under light microscopy to examine cell attachment.
To check cell orientation, MG‐63 cells were seeded at 5 × 104 cells per well on a tubular collagen‐coated scaffold in a 24‐well plate (Corning, New York, United States) and cultured for 7 days in DMEM containing 1% antibiotic–antimycotic (100×) (Gibco, Waltham, United States) and 10% FBS (Gibco, Waltham, United States). Cells adhered to the scaffolds were fixed using 2.5% glutaraldehyde for 2 h at room temperature. The scaffold was then washed twice with PBS and subsequently stained with crystal violet and imaged under light microscopy.
2.11. Complete Coverage by Cell Culturing
Custom‐made plates were made to realize 3D cell culturing. To this end, one part of curing agent was blended with 10 parts of a silicone elastomer base of PDMS and then poured as a thin layer into a 3 cm cell culture plate, followed by maintaining at 60°C for 2 h to promote full curing. Subsequently, a steel rod with a diameter 0.1 mm larger than the outer diameter of each scaffold group was placed onto the cured PDMS, after which more PDMS was poured on top to cover 80% of the steel rod, followed by maintaining at 60°C for 2 h to promote full curing. Next, the rod was removed, and the PDMS was detached from the plate. The mold‐casted PDMS was washed with 70% ethanol, sterilized in an autoclave, and then placed in a 6‐well plate. 5 × 106 HUVEC cells were dispensed into 50 µL of the cell culture medium and used to seed the scaffold, which was then placed into the mold‐casted PDMS. This was then rotated 180° every 10 min (repeated 3 times) and then every 20 min (repeated 3 times). Next, the scaffold was transferred to fresh medium, and 4 × 106 SMC cells were dispensed into 50 µL of the cell culture medium, which was then evenly dropped on the top of the scaffold surface. The scaffold was then rotated in the same manner as for the seeding procedure for HUVEC cells.
2.12. Cryosectioning and Staining
The cell‐seeded scaffold was fixed with 4% paraformaldehyde for 15 min and then washed twice with PBS. Fixed samples were embedded in cryogel (Leica, Wetzlar, Germany), transversely cut into 20 µm‐thick slices, and mounted on SuperfrostTM Plus Adhesion microscope slides (Epredia, Portsmouth, United States). The slides were then gently submerged in a solution of 0.2% Triton in 1X Phosphate‐Buffered Saline (PBST) overnight at 4°C to remove any remaining cryogel, then gently rinsed with DI water and allowed to dry.
For hematoxylin and eosin (H&E) staining, dried slides were washed twice with DI water, then gently submerged in hematoxylin for 3–8 min, and rinsed with DI water, followed by dipping in 0.2% ammonia water for 20–40 s and then in 80% ethanol for 1 min. Eosin was then added to the samples for 30 s to 3 min. Xylene was not used because it partially melted the PCL.
For immunostaining, dried slides were rinsed gently with PBS and mounted with a cover glass using mounting media with DAPI (Fluromount‐G; Invitrogen 00‐4959‐52, Waltham, United States). Prepared slides were analyzed via confocal microscopy using FITC and DAPI filters.
Non‐specific antibody reactivity was checked after photo‐bleaching the collagen‐coated scaffold for 48 h under 490–500 and 365 nm LED light to remove collagen autofluorescence, followed by blocking with 5% FBS in PBST. The samples were then rinsed with PBS and stored at 4°C overnight in a humidity chamber with 1:20 FITC‐labeled CD‐31 monoclonal antibody (Invitrogen 11‐0319‐42, Waltham, United States) in PBS or 1:40 eFluorTM 660‐labeled alpha‐smooth muscle actin (α‐SMA) monoclonal antibody (Invitrogen 50‐9760‐80, Waltham, United States). Subsequently, they were rinsed with PBS (3 times) and mounted on slides using mounting medium (Fluromount‐GTM; Invitrogen 00‐4958‐02, Waltham, United States). The prepared slides were then analyzed via confocal microscopy using FITC and eFluor 660 filters.
2.13. Microscopic Observations
The morphology and microstructure of the specimens were observed via FE‐SEM (S‐4700; Hitachi, Tokyo, Japan) after mounting the specimens using conductive tape and sputter‐coating with platinum. Light microscopy was conducted using an Eclipse Ts2 microscope (Nikon, Tokyo, Japan), and fluorescent imaging was achieved using a confocal microscope (LSM 900; Zeiss, Oberkochen, Germany).
2.14. Statistical Analysis
Results were analyzed using one‐way analysis of variance (ANOVA) with Tukey's post hoc tests for multiple comparisons using GraphPad Prism 9: significance levels are reported as * p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001.
3. Results and Discussion
3.1. The Inner Part of the Scaffold (Electrospinning)
Electrospinning is effective for fabricating micro‐ and nanosized scaffolds that mimic the ECM [58]. This eventually moves in the direction of nanotechnology and nanoscience development in terms of size, order, and structure/devices [28]. Gap electrospinning consists of two conductive plates (also called the target or receiver) with the same charge and the same distance from the needle. For the more advanced gap electrospinning technique, TPE, tubes are used rather than plates as the receiver [42]. Parallel fibers produced by gap electrospinning and TPE are useful for imitating many tissues that require parallel cell orientation [35]. Figure 1Aa displays parallel PCL fibers successfully fabricated using the gap electrospinning technique. Meanwhile, Figure 1Ab,Ac depict a low‐density tubular fiber with a diameter of 3 mm and a high‐density tubular fiber with a diameter of 5 mm fabricated using TPE.
FIGURE 1.

The inner part of the scaffold fabrication (Aa) a scaffold fabricated via gap electrospinning, and (Ab) a low‐density tubular fiber 3 mm in diameter, and (Ac) a high‐density tubular fiber 5 mm in diameter fabricated via TPE. (Ba) A schematic of the lateral view of the sacrificial material during fabrication, highlighting the gap between the fibers on the edge of the receiver tubes and the sacrificial material. FE‐SEM images showing (Bb) the scaffold folding after suturing (the suture material is human hair to show the scale of this fabrication technique better) and (Bc) at higher magnification, with the red arrows highlighting the wrinkles after suturing. The gold‐coated sacrificial material made with (Ca) a large diameter (1.75 mm) and (Cb) a small diameter (250 µm). FE‐SEM images of a 300 µm‐wide tube fabricated using the microtubular electrospinning method at (Da) low and (Db) high magnification.
Previously, TPE has been used to produce tubular fibers with much larger diameters: 19 mm in the Jha et al. study [41] and 7 mm in the Panahi Joo et al. study [42]. Reducing the diameter causes the inner lumen to become filled with fibers, and thus it is no longer a tube. In the present study, there were challenges in achieving tubular fibers with a lower diameter. Achieving well‐organized parallel‐oriented fibers requires avoiding thick fiber fabrication. Other researchers have reported that increasing the thickness of fabricated fibers results in residual charge accumulation, leading to repulsion and poor parallel fiber alignment [40]. On the other hand, being able to transfer nutrients and gases through the scaffold is crucial, which emphasizes the need for thinner tubular structures. However, after fabricating a thin layer of nanofibers via TPE, collecting them becomes very difficult because they are too fragile. Subsequently, collection distorts fiber orientation, and the tube structure collapses. To overcome this issue, the first idea was to add a non‐conductive rod inside the receiver tube before fabrication to aid fiber collection and to prevent the inside of the tube from becoming filled with fibers.
Inserting a rod inside the lumen cannot simply be added to the system, which presents some challenges. The rod should be smaller than the receiver tube, and this difference in size creates a gap. Even a micrometer‐scale gap can prevent the fibers from attaching to the rod inside the tube, which can cause distortion of the fiber organization during collection. Figure 1Ba shows a schematic of the rod location relative to the receiver tubes and the gap between the edge of the tubes and the surface of the rod. Using a suture to secure the fibers to the inner rod also results in folding the tube's outer layer and distorting the fibers’ integrity and the organization of the inside of the tube. Figure 1Bb,Bc depict the folding layers and loss of seamless tubular structure (the scaffold was sutured with human hair to display the scale of the fabrication size).
To solve the problem of folding layers, the gap needs to be reduced as much as possible. Thus, the conductive pipe (as the tube receiver) needs to be as thin as possible, and a sacrificial material should be placed between these pipes. Instead of three separate parts (two receiver tubes and a sacrificial material in between), we combined these two parts and fabricated a nano‐thick conductive tube on a PVA rod using a gold sputtering machine. Gold is a perfect conductor that can be applied as a nano‐thick coating via a well‐established sputtering technique. PVA was chosen as the sacrificial material since it is a water‐soluble dielectric that could easily be dissolved after fabrication [59]. This sacrificial material temporarily supports the nanofibers and the nano‐thick conductive tubular receiver simultaneously. PVA rods of various sizes can be manufactured through extrusion techniques. After extruding the PVA, the middle area of the rod was covered with Scotch tape. Samples were then coated on four sides using a gold sputter machine to fully cover the rod and create a nano‐thick conductive tube on the PVA. Subsequently, the Scotch tape was removed, and conductivity was checked with a multimeter set to diode test mode to ensure that all the areas were conductive. Figure 1Ca,Cb depict the sacrificial material made with two different diameters. In the present study, filaments with a diameter of approximately 1.75 mm (a standard FDM feedstock diameter) were prepared, thereby providing a gap mismatch of only a few nanometers (10–15 nm based on machine settings), which is much smaller than the diameter of the electrospun fibers.
A sacrificial material and a nano‐thick conductive tube were used to overcome the challenges of reducing the diameter of the tubular fibers fabricated via TPE. This made it possible to keep the structure intact and to subsequently produce longitudinal parallel fiber tubes less than 3 mm in diameter. Thus, parallel fiber tubes as small as 300 µm in diameter were successfully fabricated using the new technique, which is denoted microtubular electrospinning (Figure 1D). Moreover, it is possible to fabricate tubes with a diameter smaller than this with the help of thinner sacrificial materials. Based on other researchers’ results, these tubes could be fabricated to a length of 50 cm. Beachley and Wen [60] determined that PCL fibers less than 500 nm in diameter could span a gap of up to 42.5 cm, while fibers less than 1 µm in diameter could be collected using a gap of up to 50 cm.
3.2. The Outer Part of the Scaffold (4‐Axis 3D Printing)
Although filling the lumen of the tubes with fibers could be avoided, removing the sacrificial material caused the tubes to collapse, fiber disassembly due to the low‐density fabrication technique, and a lack of sufficient mechanical strength. To overcome these flaws, an extrusion 4‐axis 3D printing technique was used to create the outer part of the nanofiber structures and thereby improve the mechanical strength of the tube while maintaining the main advantage of the tubular structure (parallel longitudinal nanofibers). The process of utilizing the custom‐made fused deposition modeling (FDM) 4 Axis 3D printer to fabricate the reinforcement outer part is shown in the Figures S4 and S5.
The final assembly of the 4‐axis 3D printer apparatus is depicted in Figure 2Aa. Figure 2Ab illustrates the sacrificial material under stretch and extrusion, where molten PCL was dropped in a spiral pattern onto it. Various rotation and travel speeds were utilized, and three different reinforcement diameters were chosen to represent small, medium, and large diameters (Figure 2Ac).
FIGURE 2.

(Aa) The custom‐made part in the INVIVO FDM 3D printer. (Ab) A high‐magnification image of the tip of the printer. (Ac) Spiral reinforcement of the tube after removing the sacrificial material (without the inner fibrous tube). The process of 3D printing reinforcement and the fusion of the outer layer of the scaffold to the electrospun inner layer (B). (Ba) An illustration of the collapse of the non‐reinforced scaffold (control group), which was later reinforced (Bb) and retained its tubular fibrous structure (Bc). A photograph (Ca) and a light microscope image (Cb) of the complete scaffold. FE‐SEM images of the gaps at low magnification (Cc) and high magnification (Cd), confirming the successful fusion of the outer and inner layers.
The extrusion process uses heat and pressure to push PCL through the extruder. The gap between spiral sections was approximately 130 µm and did not differ significantly between the groups. The outer diameters of the reinforcement spirals for the 0.3, 0.6, and 1 groups were 179 ± 5.85, 238 ± 6.87, and 681 ± 12.56 µm, respectively, while the inner diameter was the same for all groups (1.75 mm), regardless of the type of reinforcement.
The control group could not maintain its shape without reinforcement (Figure 2Ba). After printing the outer layer, the process successfully maintained a perfect circular shape (Figure 2Bb), while the fibers inside retained their parallel orientation (Figure 2Bc).
Figure 2Ca shows a photo of a scaffold being held between fingers. The light microscopy image in Figure 2Cb illustrates the perfect organization of the spiral reinforcement, which was further confirmed using FE‐SEM (Figure 2Cc). By optimizing the printing temperature and deposition speed, the remaining heat was used after printing to weld the nanofibers to the outer spiral layer. In addition, the sacrificial material played a crucial role in dispersing excess heat, thereby enabling the nanofibers to attach directly to it and maintain their shape while the outer layer melted and became welded to the spiral reinforcement (Figure 2Cd).
The spiral reinforcement prevented the inner tube from collapsing and enabled the collection of small‐sized low‐density fibers from the electrospinning machine. Figure 3A shows cross‐sectional and lateral views of all of the samples, thereby confirming the reinforcement's effectiveness across all of the test groups compared to the control group. Moreover, the light microscope lateral views visualize the difference between the non‐reinforced control group and the reinforced test groups.
FIGURE 3.

Cross‐sectional views (top row) and light microscopy lateral views (bottom row) of the fabricated scaffolds (A). The scaffolds before bending (top row), at maximum bending (middle row), and after bending (bottom row) (B).
3.3. Mechanical Properties
The scaffold bendability test results show that the control group could only endure 3° of bending before the internal lumen became blocked. The minimal circumferential mechanical strength of the control group indicates its inability to withstand forces perpendicular to the lumen axis. In contrast, the 0.3‐, 0.6‐, and 1‐mm test groups could be bent to 26°, 98°, and 180°, respectively, without blocking the inner lumen (Figure 3B). These results confirm that the outer spiral reinforcement effectively enhances the resistance of the tube to blockage and helps maintain its integrity.
The circumferential strength of the test group scaffolds was significantly improved compared to the control group (Figure 4A). However, this improvement did not follow a linear trend as the nozzle size increased. This is because the number of reinforcement spiral rotations per centimeter of scaffold length decreased as the nozzle size was increased. These rotations are controlled by the “nozzle travel speed” and “DC motor rotation rate” (Table S1). For each centimeter of scaffold length in the 0.3−, 0.6−, and 1‐mm groups, there were approximately 60, 42.9, and 25 reinforcement spirals, respectively. Although the increased thickness of the reinforcement spirals enhanced the circumferential strength in the 0.6 mm group, the reduction in the number of reinforcement spirals significantly impacted the circumferential strength in the 1‐mm group. Similar findings have been reported in composite vascular grafts, where hybrid architectures require careful optimization of pitch and bonding to balance stiffness and compliance [61].
FIGURE 4.

The circumferential tensile strength and the burst pressure of the scaffolds (A). The suture‐retention strength of the scaffolds. The arrows indicate the suture position at break (B). The longitudinal tensile strength of the scaffolds (C) (* p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001).
Using the circumferential tensile strength and according to an adaptation of Laplace's law, we calculated the scaffold's estimated burst pressure (Figure 4A). All reinforced groups had significantly higher burst pressure compared to the control group. The average burst pressure of the 0.3−, 0.6−, and 1‐mm groups was approximately 2464, 6753, and 5004 mmHg compared to 15 mmHg in the control group. A typical carotid artery has a burst pressure of around 5000 mmHg, and the saphenous vein is around 2250 mmHg [62]. In Bouchet et al.’s study on SDVGs, they set their target burst pressure to 2000 mmHg for the electrospun PU/PCL scaffold [63]. All of our groups passed the target of 2000 mmHg. Our current 0.3‐mm group meets the saphenous vein range, and the 0.6‐ and 1‐mm groups could be considered for arterial application.
The suture‐retention strength results in Figure 4B demonstrate that spiral reinforcement in all groups could significantly improve the stability of the scaffold. The suture‐retention strength of the 0.3−, 0.6−, 1‐mm, and the control group was 1.44 ± 0.13, 0.88 ± 0.17, 1.05 ± 0.04, and 0.36 ± 0.04 N, respectively. The vascular transplantation standard for suture retention strength is 0.6 to 1.5 N per needle [64]. All reinforced scaffolds in our study fall within this range. Among the reinforced groups, the 0.3‐mm group showed the highest suture‐retention strength. Based on our observations, the 0.3‐mm group's behavior at break was different from the other spiral‐reinforced groups. The outer section in the former had a smaller diameter and, under tension, deformed and distributed the force from the suture more evenly, thus enabling it to withstand the tension more strongly. The outer layers in the 0.6‐ and 1‐mm groups could withstand the suture‐retention force and maintain their circular shape. However, this resulted in the suture shifting toward one side, which concentrated force in the interface between the inner and outer layers, thereby creating a high‐stress point that led to breakage and reduced suture‐retention strength. Previous studies in coil‐reinforced and textile‐reinforced grafts have shown that inadequate interfacial bonding can lead to delamination and localized strain accumulation, resulting in reduced circumferential strength [65, 66]. Computational models and experimental data further emphasize that circumferential strength in small‐diameter grafts is highly sensitive to reinforcement geometry, particularly the spiral pitch and bonding integrity [67].
There was no significant difference between the longitudinal tensile strengths of the groups (Figure 4C), which means that the highest mechanical burden is on the inner part of the scaffold. This finding is consistent with the structural orientation of the scaffold: the inner layer consisting of parallel fibers aligned along the longitudinal axis bears most of the tensile stress, while the spiral reinforcement is designed to enhance circumferential stability rather than axial strength. However, the 1‐mm group failed earlier, while its elongation was almost half that of the other groups. This can be attributed to the non‐reinforced section between each spiral in the latter being much smaller than in the other groups: approximately 7.67, 6.27, and 3.12 mm per centimeter in the 0.3‐, 0.6‐, and 1‐mm group scaffolds, respectively.
Overall, our evaluation of the scaffold's bendability, circumferential, and suture‐tension strength shows that the mechanical properties of the test groups were significantly improved compared to the control group.
3.4. Scaffold Coating, Biocompatibility, and Fiber Analysis
PCL was used for electrospinning and 3D printing of the scaffolds, after which they were coated with collagen via aminolysis based on a previously published method [48]. After Sirius Red staining, the collagen coating on the scaffolds was confirmed via polarized light microscopy (Figure 5Aa,Ab). The collagen coating on the fibers significantly reduced the water contact angle from 48° on uncoated parallel fibers to 0° on the collagen‐coated scaffolds (Figure 5Bc), thereby confirming the scaffolds’ excellent hydrophilicity (Figures 5Ba,Bb) and aligning with previous studies using the same coating technique [41]. The peak at 400.2 eV in the XPS N1s survey scans of uncoated, hexanediamide‐treated, and collagen‐coated PCL fibers in Figure 5Ca indicates successful collagen coating of the scaffolds. The amount of N in the coated scaffold samples was ∼1.8%, but absent in the uncoated PCL scaffold. (Figure 5Cb). Collagen coating is widely recognized as an effective strategy to overcome the inherent hydrophobicity of PCL, which would otherwise limit cell adhesion and proliferation. Previous studies have shown that collagen immobilization introduces functional groups that enhance wettability and protein adsorption while creating a biomimetic interface for cell attachment [68, 69]. Other studies have confirmed that collagen‐coated scaffolds exhibit markedly reduced water contact angles, thereby indicating improved hydrophilicity and favorable conditions for endothelial and smooth muscle cell adhesion [27, 70].
FIGURE 5.

Scaffold coating analysis. Dark‐field polarized light microscopy of a Sirius Red‐stained scaffold: (Aa) after collagen coating and (Ab) without collagen coating (PCL). (Bc) A graph indicating the wettability of the flat parallel scaffolds and photographs (Ba) without collagen coating and (Bb) after collagen coating. (Ca) XPS survey scans and (Cb) a plot of N content for the scaffolds (* p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001). PCL, uncoated PCL fibers; PCL‐Hexan, hexanediamide‐treated PCL fibers; PCL‐Col, collagen‐coated PCL fibers.
HUVEC cells were cultured on the scaffold to evaluate the scaffold's biocompatibility and ability to support cell organization. The microscope image in Figure 6Aa confirms that the HUVEC cells could successfully attach to the flat scaffold, while the live/dead assay results in Figure 6Ab show that 100% of the HUVEC cells attached to the scaffold were alive after 7 days of culturing, as indicated by the green fluorescence signal therein.
FIGURE 6.

The collagen‐coated scaffold's biocompatibility, ability to support cell organization, and fiber analysis. Crystal violet staining of HUVEC cells cultured on the flat collagen‐coated scaffold (Aa). Live/Dead assay results for HUVECs on the flat collagen‐coated scaffold after 7 days of culturing: a green fluorescence signal indicates live cells and a red fluorescence signal indicates dead cells (Ab). FE‐SEM images of HUVEC cells attached to the scaffold at low and high magnification (Ac). WST cell proliferation test results for HUVECs cultured on a culture plate (Plate), an uncoated PCL scaffold, and a collagen‐coated PCL (C‐PCL) scaffold after 1, 3, and 7 days of culturing (Ad). Relative cell viability test results for HUVECs after 24 h of culturing (Ae). The inner scaffold fiber diameter distribution (Ba) and fiber orientation angle (Bb). Comparison of flat scaffold and tubular scaffold fiber orientation angles (Bc) and distribution of the MG‐63 cell orientation angle (Bd) (* p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001).
Good attachment of cells to the collagen‐coated scaffold fibers can be seen in the FE‐SEM images in Figure 6Ac. At higher magnification, stretching of the cell membrane can be observed along the scaffold fibers, indicating that the cells followed the alignment direction of the fibers and that the fiber surface is favorable for cell proliferation.
Cell viability and proliferation over 1, 3, and 7 days on the collagen‐coated scaffold showed no significant difference compared to commercially treated cell plates, thus indicating good cell viability and proliferation. On the other hand, the uncoated scaffold showed significantly lower cell proliferation and viability (Figure 6Ad,Ae).
The biocompatibility assay results consistently demonstrate that the collagen‐coated PCL scaffold supports robust cell viability and proliferation compared to the uncoated control. For instance, WST assay results in a related study indicate significantly higher metabolic activity on collagen‐modified surfaces, which correlated with enhanced cytoskeletal organization and spreading [71]. This improvement is attributed to collagen's ability to mimic ECM cues, thereby facilitating integrin‐mediated adhesion and promoting cell elongation along the fiber axis, which is critical for vascular tissue engineering applications [72, 73].
The fiber diameters were 934 ± 190 nm (Figure 6Ba), while fiber orientation measurements confirmed the fiber's parallel orientation (Figure 6Bb). Moreover, the fiber's orientation on flat and tubular scaffolds was not significantly different (Figure 6Bc). Therefore, a flat scaffold was used for measuring cell orientation. Cells closely followed the fibers’ orientation (Figure 6Bd).
The size and orientation of the fibers in an ECM‐mimicking scaffold can play pivotal roles in guiding cell morphology. Electrospun fibers with a diameter below 1 µm and highly uniform alignment provide topographical cues that direct cell orientation, a phenomenon essential for replicating the anisotropic architecture of native vascular tissues [74, 75]. Uniformly aligned fibers have been shown to enhance endothelial cell alignment and smooth muscle cell elongation, thereby improving functional outcomes in engineered grafts [76].
PCL properties, including its degradation, have been extensively studied before. In our previous study, the same material scaffold, which was implanted in the rabbit gastrocnemius tendon, did not degrade during the six‐month study [27]. A number of studies by Lam et al. also showed that pure PCL and mixed PCL (with tricalcium phosphate) had no decrease in molecular weight over 6 months in vivo and in vitro, as well as over 42 months in vitro under accelerated 5 M NaOH conditions [77, 78, 79]. The long‐lasting nature of the PCL scaffold makes it a good candidate for applications that require long mechanical stability.
3.5. Cell Coverage
To seed HUVECs inside the scaffold, 5 × 106 cells were dispensed into 50 µL of medium, followed by pushing and pulling the medium multiple times to ensure that all of the scaffold had been seeded with cells (Figure 7Aa). However, this technique resulted in the accumulation of cells on one side of the scaffold: cells on the scaffold's exterior were minimally attached to the top surface and primarily attached to areas near the bottom of the culture plate. This could be due to the gravity effect on the cells before they anchor themselves to the scaffold, thereby causing them to fall to the bottom of the tube (Figure 7Ab). In general, homogeneous cell distribution is challenging in 3D cell culturing [80]. Other researchers have mentioned that initial static seeding often results in cell sedimentation and accumulation at the bottom of the lumen due to gravitational forces, leading to heterogeneous distribution and impaired tissue functionality [81]. Gravity acts on cells, and gravity settling is a technique used to harvest them by following the same principle as centrifugation in cell culture labs [82].
FIGURE 7.

Cell seeding inside the collagen‐coated scaffold lumen (Aa). H&E staining of a cross‐section of the scaffold marked by the arrow shows cell accumulation on one side (Ab). Fabrication of the custom‐made cell culture plate and its utilization (B). A schematic and photos of the custom‐made scaffold (Ba). The scaffold on day 1 of culturing (Left image) and smooth muscle cell coverage of the gaps on the outer surface after 21 days of culturing (right image) (Bb). Microscope images of cells stained with crystal violet localized (Ca) on the outside of the scaffold and (Cb, Cc) inside the same scaffold after excising a quarter of the scaffold longitudinally. The arrows in (Cc) highlight the cell orientation inside the scaffold lumen.
A custom‐made plate designed to support 3D cell culturing was used to improve homogeneous cell attachment. This custom‐made plate was mold‐cast using PDMS (Figure 7Ba), a non‐toxic material that has customizable physio‐mechanical properties, is easy to mold with high accuracy, and is cheap [83]. During cell seeding of both the inside and outside of the scaffold, the latter was rotated 3 times every 10 min and then 3 times every 20 min. The combination of the custom‐made plate and the scaffold resulted in a more even distribution of cells inside the scaffold. On the outside of the scaffold, the gap between the spiral reinforcement became filled with cells (Figure 7Bb). This approach aligns with previous research on rotational bioreactors showing enhanced homogeneity by continuously exposing the scaffold surfaces to the cell suspension, thereby reducing gravitational bias and promoting cellular infiltration [84].
Endothelial cells in a homogeneous monolayer culture become polygonal‐shaped with poorly defined borders [85], which hinders the detection of their orientation. Mg‐63 cells have a spindle shape, which facilitates visualizing their cell orientation, a phenomenon that has been used by other research on parallel fibers [86]. Furthermore, verifying the growth of another cell type on the scaffold in the present study will further demonstrate its biocompatibility. Subsequently, MG‐63 cells were cultured on the scaffold, followed by crystal violet staining both inside and outside the scaffold. Figure 7Ca shows the successful attachment of MG‐63 cells to the outer side of the scaffold. To show the interior of the same scaffold, a quarter of the scaffold was carefully excised, revealing cells aligned with the parallel orientation of the scaffold's inner fibrous part (Figure 7Cb,Cc).
H&E staining of cross‐sections of the scaffold shows the successful localization of HUVECs and SMCs within and outside of the scaffold (Figure 8A). Full coverage of the SMCs on the scaffold's exterior can be seen in Figure 8Aa, while the higher magnification images in Figure 8Ab,Ac highlight the inner scaffold being covered by HUVEC. Due to PCL's mild solubility in xylene, the latter could not be used for specimen clearing. A dissolved scaffold is highlighted in Figure 8Ad by the black arrows.
FIGURE 8.

Microscopic images of H&E‐stained cross‐sections of a high‐density cellular culture on the scaffold at low‐magnification (Aa) and high‐magnification (Ab, Ac). ∆ indicates the inner fibrous scaffold. The black arrows in (Ad) indicate the effect of xylene on the PCL scaffold. Confocal microscopy images of DAPI‐stained cells on the scaffold (B). The blue color visualizes the cell nuclei, and the green color represents collagen autofluorescence. * indicates the PCL‐reinforced spiral scaffold. Microscope images showing the non‐specific binding of CD‐31 and α‐SMA antibodies to a collagen‐coated scaffold and an uncoated PCL scaffold (C). ⊠ indicates the fibrous scaffold.
Confocal microscopy was used to visualize cell organization on the scaffold (Figure 8B). Autofluorescence is a well‐known attribute of collagen coating, which can be detected using an FITC filter. DAPI staining was used to visualize cell nuclei, and the scaffold was visualized via collagen autofluorescence. Together, these images confirm successful cell localization within and outside of the scaffold. After demonstrating successful co‐culturing on the scaffold, the latter can be used as an SDVG in future in vivo studies.
In an attempt to visualize HUVECs and SMCs on the scaffold with CD‐31 and α‐SMA conjugated antibodies, respectively, it was found that the current coating technique chemically reacted with the antibodies, leading to a high false‐positive result between the scaffold and the antibodies. Figure 8C shows non‐specific antibody reactions with the scaffold without cell culturing. Collagen and other protein‐based coatings introduce reactive sites that can interact with antibodies through hydrophobic, electrostatic, and hydrogen bonding forces, leading to false‐positive signals and high background staining [87, 88].
The advancement in nanotechnology and nanoscience could be categorized by size, order, and structures/devices [28]. We reduced the fabrication size of the seamless parallel fibrous tube while maintaining the parallel organization of the fibers and ultimately enabling the creation of structures/devices that can be used as SDVGs or other tubular structures. The combination of electrospinning with 3D printing technology improved the process‐structure‐performance relationship of the scaffold through reinforcement of the seamless tubular structure, which supported the tubular shape and fiber orientation. By adding a collagen coating, the biological capabilities of the scaffold were enhanced, which eventually put our work in the cross‐section of order and medicated nanodevices.
4. Conclusions
In this study, a novel hybrid fabrication method that combines TPE and 4‐axis 3D printing was applied to successfully produce seamless hollow PCL tubes. Improving their mechanical properties enabled the fabrication of much smaller tubes (as small as 300 µm in diameter) than have previously been reported. Unlike conventional tubular scaffolds formed by rolling flat sheets, the current approach enabled the creation of integral hollow tubes. The inner layers of the parallel PCL nanofibers provided an ECM‐like architecture that could guide cellular orientation, while the outer 3D‐printed spiral reinforcement significantly improved the mechanical properties of the tubes, including bendability, circumferential strength, and suture retention, without compromising the lumen's patency. Coating with collagen further enhanced the surface hydrophilicity of the scaffold, resulting in improved cell attachment, viability, and proliferation, as confirmed via WST assays, FE‐SEM imaging, and live/dead staining. H&E staining and confocal microscopy imaging showed the scaffold's ability to mimic the natural localization of cells. As well as being utilizable as SDVGs, the scaffold could be applicable to neural (axonal regeneration), ureter, urethra, and tendon grafts, as well as non‐biological applications such as water purification. Future work should focus on in vivo validation, long‐term patency studies, and optimization of coating protocols to enable advanced immunostaining and integration with bioactive molecules. These steps will pave the way for clinical translation and broader adoption of this technology in regenerative medicine.
Author Contributions
Seyed Aliakbar Hosseini Toopghara: conceptualization, investigation, writing – original draft, methodology, validation, visualization, software, formal analysis. Jin‐Ho Kang: resources, supervision, writing – review and editing, project administration, funding acquisition. Won‐Jae Kim: resources, formal analysis. Hochung Ryu: project administration. Young–Ook Hwang: writing – review and editing. Jeong‐Tae Koh: formal analysis, resources. Che‐I Hyun: visualization. Hyun‐Pil Lim: formal analysis. Sang‐Won Park: resources, supervision, formal analysis, data curation, project administration, writing – review and editing, visualization, funding acquisition.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Supporting File: adhm71412‐sup‐0001‐SuppMat.docx.
Acknowledgements
This work was supported by the National Research Foundation of Korea, South Korea, funded by the Korean government (MSIP) (grant Nos. 2022R1A2C2009633 and 2022R1A6A3A01087006).
Contributor Information
Jin‐Ho Kang, Email: jhk.bme1002@gmail.com, Email: dldigh8901@jnu.ac.kr.
Sang‐Won Park, Email: psw320@chonnam.ac.kr.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- 1. Tsao C. W., Aday A. W., Almarzooq Z. I., et al., “Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association,” Circulation 145, no. 8 (2022): e153–e639. [DOI] [PubMed] [Google Scholar]
- 2. Niklason L. E. and Lawson J. H., “Bioengineered Human Blood Vessels,” Science 370, no. 6513 (2020): aaw8682. [DOI] [PubMed] [Google Scholar]
- 3. Saito J., Kaneko M., Ishikawa Y., and Yokoyama U., Challenges and Possibilities of Cell‐Based Tissue‐Engineered Vascular Grafts (Cyborg and Bionic Systems, 2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Catto V., Farè S., Freddi G., and Tanzi M. C., Vascular Tissue Engineering: Recent Advances in Small Diameter Blood Vessel Regeneration (International Scholarly Research Notices, 2014). [Google Scholar]
- 5. Negishi J., Funamoto S., Kimura T., Nam K., Higami T., and Kishida A., “Porcine Radial Artery Decellularization by High Hydrostatic Pressure,” Journal of Tissue Engineering and Regenerative Medicine 9, no. 11 (2015): E144–E151. [DOI] [PubMed] [Google Scholar]
- 6. Xiong Y., Chan W. Y., Chua A. W. C., et al., “Decellularized Porcine Saphenous Artery for Small‐Diameter Tissue‐Engineered Conduit Graft,” Artificial Organs 37, no. 6 (2013): E74–E87. [DOI] [PubMed] [Google Scholar]
- 7. Lin C.‐H., Hsia K., Ma H., Lee H., and Lu J.‐H., “In Vivo Performance of Decellularized Vascular Grafts: A Review Article,” International Journal of Molecular Sciences 19, no. 7 (2018): 2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Rayatpisheh S., Heath D. E., Shakouri A., Rujitanaroj P.‐O., Chew S. Y., and MB C.‐P., “Combining Cell Sheet Technology and Electrospun Scaffolding for Engineered Tubular, Aligned, and Contractile Blood Vessels,” Biomaterials 35, no. 9 (2014): 2713–2719. [DOI] [PubMed] [Google Scholar]
- 9. Ahn H., Ju Y. M., Takahashi H., et al., “Engineered Small Diameter Vascular Grafts by Combining Cell Sheet Engineering and Electrospinning Technology,” Acta Biomaterialia 16 (2015): 14–22. [DOI] [PubMed] [Google Scholar]
- 10. Koens M. J. W., Krasznai A. G., Hanssen A. E. J., et al., “Vascular Replacement Using a Layered Elastin‐Collagen Vascular Graft in a Porcine Model: One Week Patency Versus One Month Occlusion,” Organogenesis 11, no. 3 (2015): 105–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Koens M. J. W., Faraj K. A., Wismans R. G., et al., “Controlled Fabrication of Triple Layered and Molecularly Defined Collagen/Elastin Vascular Grafts Resembling the Native Blood Vessel,” Acta Biomaterialia 6, no. 12 (2010): 4666–4674. [DOI] [PubMed] [Google Scholar]
- 12. Kumar V. A., Caves J. M., Haller C. A., et al., “Acellular Vascular Grafts Generated From Collagen and Elastin Analogs,” Acta Biomaterialia 9, no. 9 (2013): 8067–8074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Cummings C. L., Gawlitta D., Nerem R. M., and Stegemann J. P., “Properties of Engineered Vascular Constructs Made From Collagen, Fibrin, and Collagen–Fibrin Mixtures,” Biomaterials 25, no. 17 (2004): 3699–3706. [DOI] [PubMed] [Google Scholar]
- 14. Wang K., Zheng W., Pan Y., et al., “Three‐Layered PCL Grafts Promoted Vascular Regeneration in a Rabbit Carotid Artery Model,” Macromolecular Bioscience 16, no. 4 (2016): 608–618. [DOI] [PubMed] [Google Scholar]
- 15. Hasan A., Memic A., Annabi N., et al., “Electrospun Scaffolds for Tissue Engineering of Vascular Grafts,” Acta Biomaterialia 10, no. 1 (2014): 11–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Dobos A., Grandhi T. S. P., Godeshala S., Meldrum D. R., and Rege K., “Parallel Fabrication of Macroporous Scaffolds,” Biotechnology and Bioengineering 115, no. 7 (2018): 1729–1742. [DOI] [PubMed] [Google Scholar]
- 17. Hendow E. K., Guhmann P., Wright B., Sofokleous P., Parmar N., and Day R. M., “Biomaterials for Hollow Organ Tissue Engineering,” Fibrogenesis & Tissue Repair 9, no. 1 (2016): 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Boys A. J., Barron S. L., Tilev D., and Owens R. M., “Building Scaffolds for Tubular Tissue Engineering,” Frontiers in Bioengineering and Biotechnology 8 (2020): 589960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Peñaranda‐Armbrecht J., Correa‐Quiceno M. J., Caicedo‐Angulo J. C., Neuta‐Arciniegas P. A., and JÓ G.‐M., “Fabrication of Multi‐Walled Carbon Nanotube/Polycaprolactone Scaffolds for Possible Application in Tissue Engineering,” Journal of Polymer Research 31, no. 2 (2024): 64. [Google Scholar]
- 20. Kabirian F., Ditkowski B., Zamanian A., Hoylaerts M. F., Mozafari M., and Heying R., “Controlled NO‐release From 3D‐Printed Small‐Diameter Vascular Grafts Prevents Platelet Activation and Bacterial Infectivity,” ACS Biomaterials Science & Engineering 5, no. 5 (2019): 2284–2296. [DOI] [PubMed] [Google Scholar]
- 21. Pashneh‐Tala S., MacNeil S., and Claeyssens F., “The Tissue‐Engineered Vascular Graft—Past, Present, and Future,” Tissue Engineering Part B: Reviews 22, no. 1 (2016): 68–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Fazal F., Raghav S., Callanan A., Koutsos V., and Radacsi N., “Recent Advancements in the Bioprinting of Vascular Grafts,” Biofabrication 13 (2021): 032003. [DOI] [PubMed] [Google Scholar]
- 23. Shi J., Chen S., Wang L., et al., “Rapid Endothelialization and Controlled Smooth Muscle Regeneration by Electrospun Heparin‐Loaded Polycaprolactone/Gelatin Hybrid Vascular Grafts,” Journal of Biomedical Materials Research Part B: Applied Biomaterials 107, no. 6 (2019): 2040–2049. [DOI] [PubMed] [Google Scholar]
- 24. Zhu Y., Gao C., Liu X., and Shen J., “Surface Modification of Polycaprolactone Membrane via Aminolysis and Biomacromolecule Immobilization for Promoting Cytocompatibility of Human Endothelial Cells,” Biomacromolecules 3, no. 6 (2002): 1312–1319. [DOI] [PubMed] [Google Scholar]
- 25. Farndale R. W., Sixma J. J., Barnes M. J., and De Groot P. G., “The role of Collagen in Thrombosis and Hemostasis,” Journal of Thrombosis and Haemostasis 2, no. 4 (2004): 561–573. [DOI] [PubMed] [Google Scholar]
- 26. Jia L., Prabhakaran M. P., Qin X., and Ramakrishna S., “Guiding the Orientation of Smooth Muscle Cells on Random and Aligned Polyurethane/Collagen Nanofibers,” Journal of Biomaterials Applications 29, no. 3 (2014): 364–377. [DOI] [PubMed] [Google Scholar]
- 27. Hosseini Toopghara S. A., Bonakdar S., Nayyeri S., et al., “The Regenerative Capacity of Cell Imprinting and Collagen/PCL Scaffolds in Gastrocnemius Tendon Defect,” Biomaterials Science 13, no. 16 (2025): 4412–4426. [DOI] [PubMed] [Google Scholar]
- 28. Yu D.‐G. and Zhou J., “Electrospun Multi‐Chamber Nanostructures for Sustainable Biobased Chemical Nanofibers,” Next Materials 2 (2024): 100119. [Google Scholar]
- 29. Zhou J., Xue F., Xu L., Liao F., Yu D.‐G., and Ge R., “Comparative Study of Bio‐Based and Synthetic Phase Change Materials Functionalized Coaxial Fibers for Photothermal‐Controlled Drug Delivery,” Biomaterials Advances 184 (2026): 214808. [DOI] [PubMed] [Google Scholar]
- 30. Xing J., Feng J., Wang Q., Yu D.‐G., and Bligh S.‐W. A., “Recent Advances in Electrospun Nanofiber‐Based Implantable Drug Delivery Systems for Breast Cancer Therapy,” RSC Pharmaceutics 3 (2026): 276–304. [Google Scholar]
- 31. Zhang W., Wang Q., Yi W., Wang H., Yu D.‐G., and Yi T., “Electrospun PLA/PVP K90 Biphasic‐Release Sublingual Film for Motion Sickness Treatment,” Biomolecules 16, no. 3 (2026): 363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Wang P., He W., Zhou J., et al., “One‐Step Batch Fabrication of Znco ZIFs@ TiO2 Nanofibers Via Modified Triaxial Electrospinning for Enhanced Photocatalytic Antibiotic Degradation Through Peroxymonosulfate Activation,” Chemical Engineering Journal 536 (2026): 176198. [Google Scholar]
- 33. Guo Q., Lv H., Dong R., et al., “Fast Dissolving Resveratrol–Polyvinylpyrrolidone Nanofibrous Films Fabricated in Bulk Using a Special Hole Electrospinning Technique,” Polymers 18, no. 7 (2026): 795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Li D., Wang Y., and Xia Y., “Electrospinning of Polymeric and Ceramic Nanofibers as Uniaxially Aligned Arrays,” Nano Letters 3, no. 8 (2003): 1167–1171. [Google Scholar]
- 35. Cai X., Zhu P., Lu X., Liu Y., Lei T., and Sun D., “Electrospinning of Very Long and Highly Aligned Fibers,” Journal of Materials Science 52, no. 24 (2017): 14004–14010. [Google Scholar]
- 36. Zhang C., Li Y., Wang P., and Zhang H., “Electrospinning of Nanofibers: Potentials and Perspectives for Active Food Packaging,” Comprehensive Reviews in Food Science and Food Safety 19, no. 2 (2020): 479–502. [DOI] [PubMed] [Google Scholar]
- 37. Li D., Wang Y., and Xia Y., “Electrospinning Nanofibers as Uniaxially Aligned Arrays and Layer‐by‐Layer Stacked Films,” Advanced Materials 16, no. 4 (2004): 361–366. [Google Scholar]
- 38. Sell S., McClure M., Ayres C., Simpson D., and Bowlin G., “Preliminary Investigation of Airgap Electrospun Silk‐Fibroin‐Based Structures for Ligament Analogue Engineering,” Journal of Biomaterials Science, Polymer Edition 22, no. 10 (2011): 1253–1273. [DOI] [PubMed] [Google Scholar]
- 39. Kishan A. P. and Cosgriff‐Hernandez E. M., “Recent Advancements in Electrospinning Design for Tissue Engineering Applications: A Review,” Journal of Biomedical Materials Research Part A 105, no. 10 (2017): 2892–2905. [DOI] [PubMed] [Google Scholar]
- 40. Liu L. and Dzenis Y. A., “Analysis of the Effects of the Residual Charge and Gap Size on Electrospun Nanofiberalignment in a Gap Method,” Nanotechnology 19, no. 35 (2008): 355307. [DOI] [PubMed] [Google Scholar]
- 41. Jha B. S., Colello R. J., Bowman J. R., et al., “Two Pole Air Gap Electrospinning: Fabrication of Highly Aligned, Three‐Dimensional Scaffolds for Nerve Reconstruction,” Acta Biomaterialia 7, no. 1 (2011): 203–215. [DOI] [PubMed] [Google Scholar]
- 42. Panahi‐Joo Y., Karkhaneh A., Nourinia A., et al., “Design and Fabrication of a Nanofibrous Polycaprolactone Tubular Nerve Guide for Peripheral Nerve Tissue Engineering Using a Two‐Pole Electrospinning System,” Biomedical Materials 11, no. 2 (2016): 025017. [DOI] [PubMed] [Google Scholar]
- 43. Robinson A. J., Pérez‐Nava A., Ali S. C., Betzabe González‐Campos J., Holloway J. L., and Cosgriff‐Hernandez E. M., “Comparative analysis of fiber alignment methods in electrospinning,” Matter 4, no. 3 (2021): 821–844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Zhang Y. S., Yue K., Aleman J., et al., “3D Bioprinting for Tissue and Organ Fabrication,” Annals of Biomedical Engineering 45, no. 1 (2017): 148–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Placone J. K., Mahadik B., and Fisher J. P., “Addressing Present Pitfalls in 3D Printing for Tissue Engineering to Enhance Future Potential,” APL Bioengineering 4, no. 1 (2020): 010901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Wibowo A., Vyas C., Cooper G., et al., “3D Printing of Polycaprolactone–Polyaniline Electroactive Scaffolds for Bone Tissue Engineering,” Materials 13, no. 3 (2020): 512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Rohde M., Eds. Rainey F., Oren A., Methods in Microbiology (Academic Press, 2011). [Google Scholar]
- 48. Junqueira L. C. U., Bignolas G., and Brentani R. R., “Picrosirius Staining Plus Polarization Microscopy, a Specific Method for Collagen Detection in Tissue Sections,” The Histochemical Journal 11, no. 4 (1979): 447–455. [DOI] [PubMed] [Google Scholar]
- 49. Kiernan J. A., Sirius Red for collagen staining protocol (Department of Anatomy and Cell Biology, The University of Western Ontario, 2011). [Google Scholar]
- 50. Sivakumar S., Sadaiyandi V., Swaminathan S., and Ramalingam R., “Biocompatibility, Anti‐Hemolytic, and Antibacterial Assessments of Electrospun PCL/Collagen Composite Nanofibers Loaded With Acanthophora Spicifera Extracts Mediated Copper Oxide Nanoparticles,” Biocatalysis and Agricultural Biotechnology 55 (2024): 102983. [Google Scholar]
- 51. Han F., Jia X., Dai D., et al., “Performance of a Multilayered Small‐Diameter Vascular Scaffold Dual‐Loaded With VEGF and PDGF,” Biomaterials 34, no. 30 (2013): 7302–7313. [DOI] [PubMed] [Google Scholar]
- 52. Nieponice A., Soletti L., Guan J., et al., “Development of a Tissue‐Engineered Vascular Graft Combining a Biodegradable Scaffold, Muscle‐Derived Stem Cells and a Rotational Vacuum Seeding Technique,” Biomaterials 29, no. 7 (2008): 825–833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Konig G., McAllister T. N., Dusserre N., et al., “Mechanical Properties of Completely Autologous Human Tissue Engineered Blood Vessels Compared to Human Saphenous Vein and Mammary Artery,” Biomaterials 30, no. 8 (2009): 1542–1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Park S., Kim J., Lee M.‐K., et al., “Fabrication of Strong, Bioactive Vascular Grafts With PCL/Collagen and PCL/Silica Bilayers for Small‐Diameter Vascular Applications,” Materials & Design 181 (2019): 108079. [Google Scholar]
- 55. Chowdhury S. R., Mondal G., Ratnayake P., and Basu B., “Three‐Dimensional Extrusion Printed Urinary Specific Grafts: Mechanistic Insights Into Buildability and Biophysical Properties,” ACS Biomaterials Science & Engineering 10, no. 2 (2024): 1040–1061. [DOI] [PubMed] [Google Scholar]
- 56. Sakthiabirami K., Kang J.‐H., Jang J.‐G., et al., “Hybrid Porous Zirconia Scaffolds Fabricated Using Additive Manufacturing for Bone Tissue Engineering Applications,” Materials Science and Engineering: C 123 (2021): 111950. [DOI] [PubMed] [Google Scholar]
- 57. Kaipparettu B. A., Kuiatse I., Lee A. V., and Oesterreich S., “Novel Egg White–based 3‐D Cell Culture System,” Biotechniques 45, no. 2 (2018): 165–171. [DOI] [PubMed] [Google Scholar]
- 58. Ke P., Jiao X.‐N., Ge X.‐H., Xiao W.‐M., and Yu B., “From Macro to Micro: Structural Biomimetic Materials by Electrospinning,” RSC Advances 4, no. 75 (2014): 39704–39724. [Google Scholar]
- 59. Zou Q., Grottkau B. E., He Z., et al., “Biofabrication of Valentine‐Shaped Heart With a Composite Hydrogel and Sacrificial Material,” Materials Science and Engineering: C 108 (2020): 110205. [DOI] [PubMed] [Google Scholar]
- 60. Beachley V. and Wen X., “Effect of Electrospinning Parameters on the Nanofiber Diameter and Length,” Materials Science and Engineering: C 29, no. 3 (2009): 663–668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Zia A. W., Liu R., and Wu X., “Structural Design and Mechanical Performance of Composite Vascular Grafts,” Bio‐Design and Manufacturing 5, no. 4 (2022): 757–785. [Google Scholar]
- 62. Sarkar S., Salacinski H., Hamilton G., and Seifalian A., “The Mechanical Properties of Infrainguinal Vascular Bypass Grafts: Their Role in Influencing Patency,” European Journal of Vascular and Endovascular Surgery 31, no. 6 (2006): 627–636. [DOI] [PubMed] [Google Scholar]
- 63. Bouchet M., Gauthier M., Maire M., Ajji A., and Lerouge S., “Towards Compliant Small‐Diameter Vascular Grafts: Predictive Analytical Model and Experiments,” Materials Science and Engineering: C 100 (2019): 715–723. [DOI] [PubMed] [Google Scholar]
- 64. Meng X., Wang X., Jiang Y., Zhang B., Li K., and Li Q., “Suture Retention Strength of P (LLA‐CL) Tissue‐Engineered Vascular Grafts,” RSC Advances 9, no. 37 (2019): 21258–21264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Robinson A., Jiang D., Nkansah A., et al., “Advanced Manufacturing of Coil‐Reinforced Multilayer Vascular Grafts to Optimize Biomechanical Performance,” Acta Biomaterialia 198 (2025): 281–290. [DOI] [PubMed] [Google Scholar]
- 66. Zhang F., Tao H., Gluck J. M., Wang L., Daneshmand M. A., and King M. W., “A Textile‐Reinforced Composite Vascular Graft That Modulates Macrophage Polarization and Enhances Endothelial Cell Migration, Adhesion and Proliferation In Vitro,” Soft Matter 19, no. 8 (2023): 1624–1641. [DOI] [PubMed] [Google Scholar]
- 67. Li M.‐X., Wei Q.‐Q., Mo H.‐L., et al., “Challenges and Advances in Materials and Fabrication Technologies of Small‐Diameter Vascular Grafts,” Biomaterials Research 27, no. 1 (2023): 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Sousa I., Mendes A., and Bártolo P. J., “PCL Scaffolds With Collagen Bioactivator for Applications in Tissue Engineering,” Procedia Engineering 59 (2013): 279–284. [Google Scholar]
- 69. Tabatabaei F., Gelin A., Rasoulianboroujeni M., and Tayebi L., “Coating of 3D Printed PCL/TCP Scaffolds Using Homogenized‐Fibrillated Collagen,” Colloids and Surfaces B: Biointerfaces 217 (2022): 112670. [DOI] [PubMed] [Google Scholar]
- 70. Weingärtner L., Latorre S. H., Velten D., Bernstein A., Schmal H., and Seidenstuecker M., “The Effect of Collagen‐I Coatings of 3D Printed PCL Scaffolds for,” Bone Replacement on Three Different Cell Types Applied Sciences 11, no. 22 (2021): 11063. [Google Scholar]
- 71. Aminatun H. S. F., Izak R. D., Hadi S., and Amrillah T., “Fabrication and Compatibility Evaluation of Polycaprolactone/Hydroxyapatite/Collagen‐Based Fiber Scaffold for Anterior Cruciate Ligament Injury,” RSC Advances 13 (2023): 10459–10467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. He Q., Feng T., Xie Y., et al., “Recent Advances in the Development and Application of Cell‐Loaded Collagen Scaffolds,” International Journal of Molecular Sciences 26, no. 9 (2025): 4009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Mahmoodi M., Zamanifard M., Safarzadeh M., and Bonakdar S., “In Vitro Evaluation of Collagen Immobilization on Polytetrafluoroethylene Through NH3 Plasma Treatment to Enhance Endothelial Cell Adhesion and Growth,” Bio‐Medical Materials and Engineering 28, no. 5 (2017): 489–501. [DOI] [PubMed] [Google Scholar]
- 74. Niu Z., Wang X., Meng X., et al., “Controllable Fiber Orientation and Nonlinear Elasticity of Electrospun Nanofibrous Small Diameter Tubular Scaffolds for Vascular Tissue Engineering,” Biomedical Materials 14, no. 3 (2019): 035006. [DOI] [PubMed] [Google Scholar]
- 75. Murugan R. and Ramakrishna S., “Design Strategies of Tissue Engineering Scaffolds With Controlled Fiber Orientation,” Tissue Engineering 13, no. 8 (2007): 1845–1866. [DOI] [PubMed] [Google Scholar]
- 76. Jenkins T. L. and Little D., “Synthetic Scaffolds for Musculoskeletal Tissue Engineering: Cellular Responses to Fiber Parameters,” NPJ Regenerative Medicine 4, no. 1 (2019): 15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Lam C. X., Hutmacher D. W., Schantz J. T., Woodruff M. A., and Teoh S. H., “Evaluation of Polycaprolactone Scaffold Degradation for 6 Months In Vitro and In Vivo,” The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials 90, no. 3 (2009): 906–919. [DOI] [PubMed] [Google Scholar]
- 78. Lam C. X., Savalani M. M., Teoh S.‐H., and Hutmacher D. W., “Dynamics of In Vitro Polymer Degradation of Polycaprolactone‐Based Scaffolds: Accelerated Versus Simulated Physiological Conditions,” Biomedical Materials 3, no. 3 (2008): 034108. [DOI] [PubMed] [Google Scholar]
- 79. Lam C. X., Teoh S. H., and Hutmacher D. W., “Comparison of the Degradation of Polycaprolactone and Polycaprolactone–(β‐Tricalcium Phosphate) Scaffolds in Alkaline Medium,” Polymer international 56, no. 6 (2007): 718–728. [Google Scholar]
- 80. Blaudez F., Vaquette C., and Ivanovski S., “Cell Seeding on 3D Scaffolds for Tissue Engineering and Disease Modeling Applications,” Oral Biology: Molecular Techniques and Applications (Springer, 2022). [DOI] [PubMed] [Google Scholar]
- 81. Campos Marín A., Brunelli M., and Lacroix D., “Flow Perfusion Rate Modulates Cell Deposition Onto Scaffold Substrate During Cell Seeding,” Biomechanics and Modeling in Mechanobiology 17, no. 3 (2018): 675–687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Dryden W. A., Larsen L. M., Britt D. W., and Smith M. T., “Technical and Economic Considerations of Cell Culture Harvest and Clarification Technologies,” Biochemical Engineering Journal 167 (2021): 107892. [Google Scholar]
- 83. Etezadi F., Le M. N. T., Shahsavarani H., et al., “Optimization of a PDMS‐Based Cell Culture Substrate for High‐Density Human‐Induced Pluripotent Stem Cell Adhesion and Long‐Term Differentiation Into Cardiomyocytes Under a Xeno‐Free Condition,” ACS Biomaterials Science & Engineering 8, no. 5 (2022): 2040–2052. [DOI] [PubMed] [Google Scholar]
- 84. Leferink A. M., Chng Y.‐C., Van Blitterswijk C. A., and Moroni L., “Distribution and Viability of Fetal and Adult Human Bone Marrow Stromal Cells in a Biaxial Rotating Vessel Bioreactor After Seeding on Polymeric 3D Additive Manufactured Scaffolds,” Frontiers in Bioengineering and Biotechnology 3 (2015): 169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Jaffe E. A., Nachman R. L., Becker C. G., and Minick C. R., “Culture of Human Endothelial Cells Derived From Umbilical Veins. Identification by Morphologic and Immunologic Criteria,” Journal of Clinical Investigation 52, no. 11 (1973): 2745–2756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Wang B., Cai Q., Zhang S., Yang X., and Deng X., “The Effect of Poly (L‐Lactic Acid) Nanofiber Orientation on Osteogenic Responses of Human Osteoblast‐Like MG63 Cells,” Journal of the Mechanical Behavior of Biomedical Materials 4, no. 4 (2011): 600–609. [DOI] [PubMed] [Google Scholar]
- 87. Tsutsumi Y., “Pitfalls and Caveats in Applying Chromogenic Immunostaining to Histopathological Diagnosis,” Cells 10, no. 6 (2021): 1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Bacenkova D., Trebunova M., and Cajkova J., “Enhancing Biomaterial Performance: The Advantages and Applications of Collagen Coating,” Acta Tecnología 11, no. 1 (2025): 25–30. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting File: adhm71412‐sup‐0001‐SuppMat.docx.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
